Travere Therapeutics, Inc. (TVTX)

34.48 4.83 (16.29%)

As of 2025-10-30 20:22:53 EST

Martin Shkreli (/ˈʃkrɛli/; born March 17, 1983) is an American investor and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.

Traded asNasdaq: TVTX
ISINUS89422G1076
CIK0001438533
LEI—
EIN262383102
Sector—
IndustryPharmaceutical Preparations
CEO—
Employees—
Fiscal Year End1231
Address3611 VALLEY CENTRE DR, SAN DIEGO, CA, 92130
Phone888-969-7879
Website—
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
TVTXTravere Therapeutics, Inc.2025-10-30 20:22:5334.484.8316.29
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
TVTX0001438533Travere Therapeutics, Inc.US89422G1076—262383102Nasdaq2834Pharmaceutical Preparations1231CA3611 VALLEY CENTRE DRSAN DIEGOCA92130UNITED STATESUS888-969-78793611 VALLEY CENTRE DR, SAN DIEGO, CA, 921303611 VALLEY CENTRE DR, SAN DIEGO, CA, 92130Retrophin, Inc.—2011———624,140,48289,102,34789,138,673Martin Shkreli (/ˈʃkrɛli/; born March 17, 1983) is an American investor and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.2025-10-30 14:12:51
This is a preview of the latest data. Subscribe to access the full data.
TVTX Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
TVTX Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2024624,140,482-521,273,027-45.509688,739,82612,641,34116.6118
20231,145,413,509-393,357,757-25.563176,098,48511,353,49517.5357
20221,538,771,266659,388,22574.98364,744,9901,533,4252.4259
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Peter HeermaChief Commercial Officer2024503,7500299,155353,50014,6971,513,360
Jula InrigChief Medical Officer2024522,0830299,155367,50013,3781,681,277
Eric DubeChief Executive Officer, President, Director2024822,00001,607,400865,20014,6975,204,877
Christopher ClineChief Financial Officer2024497,5000299,155350,00012,6071,501,520
Elizabeth ReedSenior Vice President2023468,4170648,327230,30014,9172,018,708
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2024385
2023380
2022462
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue233,175,000145,238,000212,018,000
Cost Of Revenue7,744,00011,450,0007,592,000
Gross Profit———
Research And Development Expenses217,496,000244,990,0007,500,000
General And Administrative Expenses264,119,000265,542,000220,206,000
Operating Expenses557,002,000533,376,000478,584,000
Operating Income-323,827,000-388,138,000-266,566,000
Net Income-321,545,000-111,399,000-278,482,000
Earnings Per Share Basic-4.08-1.5-4.37
Earnings Per Share Diluted-4.08-1.5-4.37
Weighted Average Shares Outstanding Basic78,888,86174,267,41863,758,515
Weighted Average Shares Outstanding Diluted78,888,86174,267,41863,758,515
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents58,535,00058,176,00061,688,000
Marketable Securities Current73,325,000248,638,000285,526,000
Accounts Receivable27,116,00021,179,00016,646,000
Inventories6,200,0009,410,0006,922,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current416,702,000616,775,000486,437,000
Marketable Securities Non Current—260,037,000103,031,000
Property Plant And Equipment5,336,0007,479,0009,049,000
Other Assets Non Current18,162,00010,661,00011,061,000
Total Assets Non Current4,500,000172,138,000186,148,000
Total Assets594,125,000788,913,000672,585,000
Accounts Payable23,534,00041,675,00017,290,000
Deferred Revenue2,815,0007,096,00011,976,000
Short Term Debt———
Other Liabilities Current14,291,0005,237,0005,722,000
Total Liabilities Current200,751,000177,908,000142,163,000
Long Term Debt310,310,000377,263,000375,545,000
Other Liabilities Non Current6,796,0008,485,0009,385,000
Total Liabilities Non Current334,297,000410,195,000487,571,000
Total Liabilities535,048,000588,103,000629,734,000
Common Stock9,0007,0006,000
Retained Earnings-1,447,167,000-1,125,622,000-1,014,223,000
Accumulated Other Comprehensive Income-80,000-1,456,000-2,907,000
Total Shareholders Equity59,077,000200,810,00042,851,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization43,555,00038,530,00033,079,000
Share Based Compensation Expense36,913,00044,246,00039,177,000
Other Non Cash Income Expense-7,944,0003,626,000-972,000
Change In Accounts Receivable6,001,00011,264,000682,000
Change In Inventories3,771,00039,420,0002,064,000
Change In Non Trade Receivables41,00035,000374,000
Change In Other Assets———
Change In Accounts Payable-17,563,00024,763,0002,307,000
Change In Other Liabilities5,646,000-418,000-1,723,000
Cash From Operating Activities-237,475,000-280,021,000-186,291,000
Purchases Of Marketable Securities125,757,000443,942,000385,389,000
Sales Of Marketable Securities326,334,000334,575,000382,000,000
Acquisition Of Property Plant And Equipment—668,000191,000
Acquisition Of Business——0
Other Investing Activities40,0000600,000
Cash From Investing Activities99,325,00055,776,000-32,553,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock134,738,000191,198,0002,978,000
Repurchase Of Common Stock———
Issuance Of Long Term Debt———
Repayment Of Long Term Debt———
Other Financing Activities———
Cash From Financing Activities139,422,000218,752,000117,573,000
Change In Cash359,000-3,512,000-104,065,000
Cash At End Of Period58,535,00058,176,00061,688,000
Income Taxes Paid453,000578,000996,000
Interest Paid8,838,0008,838,00010,159,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share-4.08-1.5-4.37
Price To Earnings Ratio-4.2696-5.9933-4.8124
Earnings Growth Rate172-65.675145.1827
Price Earnings To Growth Ratio-0.02480.0913-0.1065
Book Value Per Share0.74892.70390.6721
Price To Book Ratio23.26193.324931.2908
Ebitda-266,355,000-60,991,000-233,107,000
Enterprise Value1,626,018,958.62986,751,087.821,654,698,570.45
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio5.25261.87878.764
Capital Expenditures41,412,00036,960,00031,022,000
Free Cash Flow-278,887,000-316,981,000-217,313,000
Return On Equity-5.4428-0.5547-6.4988
One Year Beta1.29291.23641.0221
Three Year Beta1.10111.02660.9484
Five Year Beta0.99160.99081.0213
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER2025-10-2927,128A446,301
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER2025-10-2927,128D419,173
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER2025-10-2927,128D180,000
Heerma PeterCHIEF COMMERCIAL OFFICER2025-10-282,662D124,662
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER2025-10-2892,872A512,045
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
JENNISON ASSOCIATES LLC2025-09-3025,915,9651,084,35023.9
TEACHER RETIREMENT SYSTEM OF TEXAS2025-09-30494,72920,70023.9
Parkside Financial Bank & Trust2025-09-301,6977123.9014
EMERALD MUTUAL FUND ADVISERS TRUST2025-09-3028,702,5141,200,94223.9
EMERALD ADVISERS, LLC2025-09-3051,307,7312,146,76723.9
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
FORUM FUNDS2025-09-30Lisanti Small Cap Growth FundASCGX4,905117,229.50.735
SEI INSTITUTIONAL INVESTMENTS TRUST2025-08-31SIIT Extended Market Index Fund - Class ASMXAX12,700222,2500.0183
ALPS ETF Trust2025-08-31ALPS Medical Breakthroughs ETFSBIO42,072736,2600.9092
VALIC Co I2025-08-31Small Cap Value FundVVSCX30,250529,3750.2223
Exchange Place Advisors Trust2025-08-31CLASS AORSAX30,790538,8250.0941
This is a preview of the latest data. Subscribe to access the full data.